Is Mezzion PharmaLtd (KOSDAQ:140410) A Risky Investment?
Feb 06
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies105
- 7D-3.0%
- 3M21.8%
- 1Y34.5%
- YTD15.6%
Over the last 7 days, the Pharma industry has dropped 3.0%, driven by a pullback from Mezzion PharmaLtd of 19%. In contrast, Hanmi Pharm has gained 14%. In the past year, the industry has gained 35%. As for the next few years, earnings are expected to grow by 37% per annum.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | ₩81.1t | ₩31.4t | ₩1.2t | 15.9x | 68.5x | 2.6x |
| Tue, 06 Jan 2026 | ₩71.6t | ₩31.4t | ₩1.2t | 16.9x | 60.4x | 2.3x |
| Thu, 04 Dec 2025 | ₩73.5t | ₩31.6t | ₩1.2t | 15.1x | 61.2x | 2.3x |
| Sat, 01 Nov 2025 | ₩66.7t | ₩31.3t | ₩1.0t | 18.7x | 66.5x | 2.1x |
| Mon, 29 Sep 2025 | ₩61.9t | ₩31.1t | ₩925.9b | 20.4x | 66.9x | 2x |
| Wed, 27 Aug 2025 | ₩59.2t | ₩31.0t | ₩887.5b | 20.7x | 66.7x | 1.9x |
| Fri, 25 Jul 2025 | ₩61.0t | ₩30.4t | ₩918.0b | 17.5x | 66.5x | 2x |
| Sun, 22 Jun 2025 | ₩54.6t | ₩30.1t | ₩903.8b | 16.1x | 60.4x | 1.8x |
| Tue, 20 May 2025 | ₩51.7t | ₩29.6t | ₩971.4b | 17.4x | 53.2x | 1.7x |
| Thu, 17 Apr 2025 | ₩52.1t | ₩29.6t | ₩984.4b | 17.6x | 52.9x | 1.8x |
| Sat, 15 Mar 2025 | ₩54.9t | ₩29.6t | ₩1.0t | 13.4x | 52.5x | 1.9x |
| Mon, 10 Feb 2025 | ₩58.7t | ₩29.6t | ₩1.0t | 11.9x | 57.5x | 2x |
| Wed, 08 Jan 2025 | ₩57.0t | ₩29.7t | ₩994.8b | 13.3x | 57.3x | 1.9x |
| Fri, 06 Dec 2024 | ₩51.3t | ₩29.4t | ₩988.8b | 11.5x | 51.9x | 1.7x |
| Sun, 03 Nov 2024 | ₩58.1t | ₩28.7t | ₩833.2b | 14.7x | 69.8x | 2x |
| Tue, 01 Oct 2024 | ₩58.7t | ₩28.8t | ₩836.8b | 15.1x | 70.1x | 2x |
| Thu, 29 Aug 2024 | ₩60.1t | ₩28.7t | ₩894.5b | 15.6x | 67.2x | 2.1x |
| Sat, 27 Jul 2024 | ₩55.7t | ₩28.4t | ₩762.2b | 14.6x | 73.1x | 2x |
| Mon, 24 Jun 2024 | ₩52.7t | ₩30.2t | ₩909.6b | 13.5x | 57.9x | 1.7x |
| Wed, 22 May 2024 | ₩54.2t | ₩29.7t | ₩930.5b | 17x | 58.3x | 1.8x |
| Fri, 19 Apr 2024 | ₩50.5t | ₩29.4t | ₩922.9b | 16.5x | 54.7x | 1.7x |
| Sun, 17 Mar 2024 | ₩53.2t | ₩29.7t | ₩728.2b | 20.5x | 73.1x | 1.8x |
| Tue, 13 Feb 2024 | ₩50.8t | ₩29.6t | ₩593.1b | 21.3x | 85.6x | 1.7x |
| Thu, 11 Jan 2024 | ₩54.4t | ₩29.6t | ₩588.5b | 23.7x | 92.4x | 1.8x |
| Sat, 09 Dec 2023 | ₩50.7t | ₩29.6t | ₩590.4b | 22x | 85.9x | 1.7x |
| Mon, 06 Nov 2023 | ₩46.5t | ₩29.3t | ₩683.3b | 15.8x | 68.1x | 1.6x |
| Wed, 04 Oct 2023 | ₩50.9t | ₩29.3t | ₩683.3b | 17.1x | 74.5x | 1.7x |
| Fri, 01 Sep 2023 | ₩51.2t | ₩29.3t | ₩677.3b | 16.6x | 75.6x | 1.7x |
| Sun, 30 Jul 2023 | ₩48.9t | ₩28.8t | ₩884.1b | 21.7x | 55.3x | 1.7x |
| Tue, 27 Jun 2023 | ₩47.9t | ₩28.9t | ₩908.3b | 20.9x | 52.8x | 1.7x |
| Thu, 25 May 2023 | ₩48.5t | ₩28.7t | ₩878.4b | 22.3x | 55.2x | 1.7x |
| Sat, 22 Apr 2023 | ₩47.9t | ₩28.5t | ₩602.7b | 21x | 79.5x | 1.7x |
| Mon, 20 Mar 2023 | ₩44.8t | ₩27.8t | ₩637.1b | 19.6x | 70.3x | 1.6x |
| Wed, 15 Feb 2023 | ₩45.2t | ₩27.7t | ₩743.5b | 20.3x | 60.8x | 1.6x |
Price to Earnings Ratio
60.8x
Current Industry PE
- Investors are optimistic on the South Korean Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 68.5x which is higher than its 3-year average PE of 65.4x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 4.3% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -3.04% | |
| Healthcare | -4.89% | |
| Pharma | -3.02% | |
| Pharma | -3.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A128940 Hanmi Pharm | ₩552.00k | 14.0% +₩862.3b | 114.4% | PE60.1x | |
| A000250 Sam Chun Dang Pharm | ₩500.00k | 4.1% +₩453.5b | 148.8% | PS52.7x | |
| A001060 JW Pharmaceutical | ₩33.45k | 7.6% +₩53.8b | 39.4% | PE13.2x | |
| A041960 Komipharm International | ₩7.50k | 5.2% +₩26.8b | 90.8% | PS9.6x | |
| A185750 Chong Kun Dang Pharmaceutical | ₩87.00k | 1.8% +₩19.8b | 5.6% | PE19.3x |
